PortfoliosLab logoPortfoliosLab logo
HQL vs. IYH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HQL vs. IYH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tekla Life Sciences Investors (HQL) and iShares U.S. Healthcare ETF (IYH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HQL achieves a 25.27% return, which is significantly higher than IYH's 5.42% return. Over the past 10 years, HQL has outperformed IYH with an annualized return of 10.15%, while IYH has yielded a comparatively lower 9.52% annualized return.


HQL

1D
2.23%
1M
-2.09%
6M
22.43%
YTD
25.27%
1Y
67.53%
3Y*
28.98%
5Y*
9.74%
10Y*
10.15%
ALL TIME*
8.70%

IYH

1D
0.00%
1M
-1.40%
6M
6.20%
YTD
5.42%
1Y
23.51%
3Y*
8.40%
5Y*
4.69%
10Y*
9.52%
ALL TIME*
7.99%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$3.56M$3.20M$2.54M
$81.05M$58.47M$58.18M

HQL vs. IYH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
HQL
Tekla Life Sciences Investors
25.27%45.48%11.03%4.23%-19.21%5.52%23.72%25.53%-16.18%25.41%
IYH
iShares U.S. Healthcare ETF
5.42%13.16%2.99%2.14%-4.46%23.41%15.56%20.80%5.80%22.27%

Correlation

The correlation between HQL and IYH is 0.44, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.44

Correlation (3Y)
Balances recent behavior with more history.

0.57

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.63

Correlation (10Y)
Provides a long-term view across more market conditions.

0.67

Correlation (All Time)
Calculated using the full available price history since Jun 16, 2000

0.62

The correlation between HQL and IYH shifts across timeframes, from 0.44 (1 year) to 0.67 (10 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HQL vs. IYH — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

HQL
HQL Risk / Return Rank: 9797
Overall Rank
HQL Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
HQL Sortino Ratio Rank: 9797
Sortino Ratio Rank
HQL Omega Ratio Rank: 9595
Omega Ratio Rank
HQL Calmar Ratio Rank: 9797
Calmar Ratio Rank
HQL Martin Ratio Rank: 9797
Martin Ratio Rank

IYH
IYH Risk / Return Rank: 5454
Overall Rank
IYH Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
IYH Sortino Ratio Rank: 6464
Sortino Ratio Rank
IYH Omega Ratio Rank: 5353
Omega Ratio Rank
IYH Calmar Ratio Rank: 5555
Calmar Ratio Rank
IYH Martin Ratio Rank: 4343
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

HQL vs. IYH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tekla Life Sciences Investors (HQL) and iShares U.S. Healthcare ETF (IYH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HQLIYHDifference
Sharpe ratioReturn per unit of total volatility

+1.61

Sortino ratioReturn per unit of downside risk

+1.63

Omega ratioGain probability vs. loss probability

1.49

1.27

+0.23

Calmar ratioReturn relative to maximum drawdown

6.62

2.22

+4.40

Martin ratioReturn relative to average drawdown

19.18

5.25

+13.93

HQL vs. IYH - Sharpe Ratio Comparison

The current HQL Sharpe Ratio is 3.12, which is higher than the IYH Sharpe Ratio of 1.52. The chart below compares the historical Sharpe Ratios of HQL and IYH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HQL vs. IYH - Drawdown Comparison

The maximum HQL drawdown since its inception was -62.65%, which is greater than IYH's maximum drawdown of -43.12%. Use the drawdown chart below to compare losses from any high point for HQL and IYH.


Loading charts...

Drawdown Indicators


HQLIYHDifference

Max Drawdown

Largest peak-to-trough decline

-62.65%

-43.12%

-19.53%

Max Drawdown (1Y)

Largest decline over 1 year

-10.25%

-10.64%

+0.39%

Max Drawdown (3Y)

Largest decline over 3 years

-25.10%

-17.91%

-7.19%

Max Drawdown (5Y)

Largest decline over 5 years

-38.86%

-17.91%

-20.95%

Max Drawdown (10Y)

Largest decline over 10 years

-38.86%

-28.40%

-10.46%

Current Drawdown

Current decline from peak

-5.42%

-2.92%

-2.50%

Average Drawdown

Average peak-to-trough decline

-22.17%

-8.92%

-13.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.53%

4.50%

-0.97%

Volatility

HQL vs. IYH - Volatility Comparison

Tekla Life Sciences Investors (HQL) has a higher volatility of 6.72% compared to iShares U.S. Healthcare ETF (IYH) at 5.17%. This indicates that HQL's price experiences larger fluctuations and is considered to be riskier than IYH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HQLIYHDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.72%

5.17%

+1.55%

Volatility (6M)

Calculated over the trailing 6-month period

15.67%

12.02%

+3.65%

Volatility (1Y)

Calculated over the trailing 1-year period

21.77%

15.61%

+6.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.93%

15.23%

+5.70%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.28%

16.82%

+5.46%

Dividends

HQL vs. IYH - Dividend Comparison

HQL's dividend yield for the trailing twelve months is around 10.36%, more than IYH's 1.17% yield.


PositionTTM20252024202320222021202020192018201720162015
HQL
Tekla Life Sciences Investors
10.36%10.85%14.18%9.44%9.57%8.79%7.90%8.03%10.72%8.25%12.18%11.84%
IYH
iShares U.S. Healthcare ETF
1.17%1.19%1.25%1.18%1.10%0.94%1.16%1.14%1.95%1.10%1.29%2.02%

Frequently Asked Questions


HQL and IYH have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HQL has higher volatility (6.72%) compared to IYH (5.17%). In terms of maximum drawdown, HQL dropped -62.65% vs IYH's -43.12%.

HQL currently has the higher Sharpe Ratio (3.12 vs 1.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HQL and IYH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer